제품 > 재조합 단백질

Recombinant SARS-COV-2 NSP7&NSP8 Protein (RP02651)

Datasheet

Overview

Product nameRecombinant SARS-COV-2 NSP7&NSP8 Protein
Catalog No.RP02651
DescriptionSARS-COV-2 NSP7&NSP8 Protein is expressed from E.coil with His tag at the C-terminal.;It contains Ser1-Gln83(NSP7)&Ala1-Gln198(NSP8).
Purity> 95% as determined by Tris-Bis PAGE
EndotoxinLess than 1EU per μg by the LAL method.
SpeciesSARS-CoV-2
Calculated MW32.8 kDa
The crystal structure of the metabolite of remdesivir (Monophosphate of GS-441524) and NSP12-NSP8-NSP7 of SARS CoV-2 virus was recently reported. The crystal structures of ADP-Ribose or AMP and NSP3 of SARS CoV-2 virus were also released, recently. The crystal structure of NSP3 of SARS CoV-2 virus as an alternative binding site of AMP or ADP-ribose to treat COVID-19.
SynonymSP7&NSP8; nsp7&nsp8
Expression HostE. coli
TagC-His
Swiss-Prot
Gene ID
StorageStore at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.
ReconstitutionCentrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.

* For research use only. Not for therapeutic or diagnostic purposes.

용량을 선택하세요
문의하기